BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2010
View Archived Issues
Regeneron provides data on two antibody product candidates
Read More
Preclinical and clinical data on dual FXR/TGR5 agonist INT-767 disclosed by Intercept
Read More
Vertex discovers novel CFTR channel modulators
Read More
New CREB-mediated gene transcription inhibitors claimed by U.S. scientists
Read More
Merck & Co. describes novel orexin receptor antagonists
Read More
Snapshots: Recent data on denosumab for postmenopausal osteoporosis
Read More
Bayer's BAY-80-6946 induces regression in tumor models
Read More
Macrolides CSY-3655 and CSY-0073 show promise in mouse models of inflammation
Read More
Fixed-dose ibuprofen/famotidine combination HZT-501 evaluated in healthy volunteers
Read More
Promising interim phase I/II data on TNF-alpha kinoid in Crohn's disease
Read More
Phase I data support clinical activity of BMS-790052 in HCV genotype 1a/1b infection
Read More
EMA issues positive opinion for orphan status of AEZS-108 in ovarian cancer
Read More
Inovio Biomedical becomes Inovio Pharmaceuticals
Read More
Celldex begins phase II trial of CDX-1307 in bladder cancer
Read More
Geron reports preclinical data on heart failure therapeutic candidate GRNCM-1
Read More
FDA grants NeoPharm's IL13-PE38QQR orphan drug status for IPF
Read More
FDA grants orphan drug status to Allos' pralatrexate for bladder cancer
Read More
Primary endpoint met in phase I iCo-007 trial in diffuse diabetic macular edema
Read More
Gruenenthal claims novel bradykinin B1 receptor antagonists
Read More
Teva reports phase II data on talampanel in ALS
Read More
FDA approves Roxro Pharma's Sprix nasal spray for acute pain
Read More
AbD Serotec provides anti-idiotype antibodies as tools for research and development
Read More
LEAD Therapeutics presents novel antibacterial agents
Read More
Cerenis reports phase I data on CER-001 in cardiovascular disease
Read More
Amarillo Biosciences presents new phase II data on oral interferon for cold and flu
Read More
Chelsea Therapeutics reports on long-term safety trial of Northera
Read More
Pfizer and Washington University enter into collaboration agreement
Read More